TETRA Technologies, Inc. (TTI) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

63OpportunityDD: Jun 20, 2026Analyst: 68

paidPrice at analysis date

USD 10.2 (20/06/2026)

domainMkt cap

$1.50B

pie_chartShares

candlestick_chart52W

$3.06-$12.54

trending_downShort interest

6.5%

INFONYSEMaterials1400 employeesFounded 1981

Verdict: Moderately Attractive —

Multi-segment energy services platform (FY25 revenue $631M, Q1-26 adj. EBITDA $25.6M, net leverage 1.5x) re-rated from $3 to $10+ in 12M on credible critical-minerals optionality (Arkansas bromine FID approved May-26, NPV $607M; Argentina EPF contracts doubling local revenue). Asymmetry hypothesized in screening only partially holds: market is already pricing ~70% of Evergreen NPV at 19.7x EV/EBITDA TTM (vs. oilfield-services peers at 5-7x). Insider buying credible; June $100M secondary at $9.25 absorbed dilution risk. Fair value $9-12 base, modest upside, capital intensity in 2027-28 the swing factor.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-06-20

TETRA Technologies, Inc. (TTI)

Energy Services + Specialty Chemicals · NYSE · Spring, TX

"Credible multi-catalyst story already 70% priced; asymmetry from screening only partially holds."

Profitable Q1-26 19.7x EV/EBITDA Bromine FID approved Capex ramp 2027-28 Insider buying

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — Sum-of-the-Parts (SotP)

Fair value base case

USD 10.4

Range: USD 7.50-USD 14.2

Price at analysis date: USD 10.2 (20/06/2026)

Base upside/downside: +2%

Methodology: Primary method is SotP with peer-median EV/EBITDA (6.5x) on core energy services + probability-weighted NPV ($425M risk-adjusted) on Evergreen bromine. Cross-check: forward EV/EBITDA on FY27E EBITDA $150M at 8x = $9.95/share (within 5% of base FV $10.40, confirms convergence). Sensitivity: ±2x in multiple shifts FV by ±$2.60/share (±25%) — significant but not extreme. The asymmetry profile hypothesized in screening (downside ≤40%, upside ≥60%, ratio ≥2.5x) does not fully materialize at current price : implied downside −47%, implied upside +44%, ratio 0.9x. Verdict: fair value ≈ market price; insider buying and FID approval reduce execution risk, but valuation already captures the catalyst. ⚠️ Not investment advice.

Component	Assumption	USD/share
Core energy services + completion fluids (EV)	FY26E EBITDA $130M × 6.5x EV/EBITDA = $845M EV / 146M sh	+$5.79
Net debt (post-secondary)	Cash $131M (Q1 $35.5M + $96M net from June raise) − debt $182M = −$51M / 146M sh	−$0.35
Evergreen bromine plant — risk-weighted NPV	$607M company NPV × 70% P[execution] = $425M / 146M sh	+$2.91
Lithium/magnesium optionality (JV w/ Magrathea)	25% probability × est. $250M NPV = $62.5M / 146M sh	+$0.43
Argentina EPF revenue ramp (already in EBITDA, optionality only)	Upside to Sandstorm Middle East + Argentina doubling: 30% × $100M NPV / 146M sh	+$0.21
Future dilution from 2027-28 capex (haircut)	Probability-weighted further secondary $150M @ $10/sh ≈ 15M shares add'l = 10% dilution	−$0.58
FV base case	Algebraic sum of components above	≈ $8.41

Bull

$13–17

Probability: 25%

Evergreen plant on time and on budget; bromine prices firm; lithium/magnesium JV converted to financed project; no further equity raise. 8x EV/EBITDA on $170M FY27E.

Base

USD 8.84-USD 12.0

Probability: 50%

Single-digit revenue growth as guided; Evergreen progresses but with mild delay; one further $100-150M secondary in 2027 to fund capex. SotP $8-11.

Bear

$5–7

Probability: 25%

Oilfield services cyclical downturn; Evergreen delayed past 2028; multiple compression to 4-5x core EBITDA with NPV haircut to 30%. Lithium optionality goes to zero.

Methodology: Methodology: Primary method is SotP with peer-median EV/EBITDA (6.5x) on core energy services + probability-weighted NPV ($425M risk-adjusted) on Evergreen bromine. Cross-check: forward EV/EBITDA on FY27E EBITDA $150M at 8x = $9.95/share (within 5% of base FV $10.40, confirms convergence). Sensitivity: ±2x in multiple shifts FV by ±$2.60/share (±25%) — significant but not extreme. The asymmetry profile hypothesized in screening (downside ≤40%, upside ≥60%, ratio ≥2.5x) does not fully materialize at current price : implied downside −47%, implied upside +44%, ratio 0.9x. Verdict: fair value ≈ market price; insider buying and FID approval reduce execution risk, but valuation already captures the catalyst. ⚠️ Not investment advice. Not investment advice.

⚠️ Methodology note: TTI is a hybrid energy-services / critical-minerals story. Sum-of-the-parts is the primary FV method: (i) going-concern EBITDA multiple on core oilfield services + completion fluids; (ii) probability-weighted NPV on Evergreen Arkansas bromine plant (FID approved 2026-05-28, first production targeted 2028); (iii) optionality on lithium/magnesium JV. Pure peer EV/EBITDA understates the optionality; pure NPV double-counts what is already in the operating EBITDA. SotP is the only honest framing.

📊 Capital Structure · Short Interest · Buyback & Dilution

🟡 Short Interest

~6.5%

~9M shares short / ~146M outstanding. Interpretation: moderate, no squeeze setup; consistent with re-rating debate (bromine bulls vs. dilution bears).

🔴 Share Dilution (1Y)

+10.8%

From ~132M to ~146M shares. Cause: June 2, 2026 secondary of 10.81M shares at $9.25 = $100M gross. Use of proceeds: Arkansas bromine capex. Additional 2027-28 raises probable as capex peaks.

🔴 Buyback

No buyback program active. Priority: fund $220M+ remaining Evergreen capex through FCF + selective equity. Dividend also at $0 — capital fully allocated to growth.

Short Interest — context

TTI — 6.5%

6.5%

Short interest moderate (~5-15% band). No squeeze dynamics. Insider activity: Kurt Hallead (VP-Treasurer & IR) — third open-market purchase since May 2025, latest 22,000 shares ($217K), holdings 0 → 170,764. No insider selling reported in last 12 months. Material 2026 events: (1) May 28, FID approved for Arkansas bromine; (2) June 2, $100M secondary priced at $9.25 (low end of $9.25-$9.75 range, JPMorgan lead); (3) no class action / no short-seller report / no SEC investigation in last 12 months. No going-concern signals.

$Financial analysis — FY 2025–2026E

FY25 Revenue

$631M

+5.3% YoY (vs $599M FY24)

Q1-26 Adj. EBITDA

$25.6M

10Y high in Q1 revenue + EBITDA

Net leverage

1.5x

Q1-26 pre-secondary; ~1.0x post

EV/EBITDA TTM

19.7x

~4-5x oilfield-services peer median

Item	FY2023	FY2024	FY2025	FY2026E	Guidance 2026
Revenue ($M)	569	599	631	662	Single-digit growth
Adj. EBITDA ($M)	105	113	118	~130	Completion fluids 25-30% margin; W&F mid-teens
Net income ($M)	13	26	3	~25	FY25 one-off tax items distort
EPS diluted ($)	0.10	0.20	0.82*	~0.17	*FY25 includes tax benefit; underlying $0.10-0.15
Net debt ($M)	183	156	146	~50	Post-June secondary $100M
Net leverage (x)	1.7	1.4	1.2	~0.4	Will rise again 2027-28 with Evergreen capex

Source: TTI Q1-26 release, FY25 10-K, June 2 2026 secondary prospectus. FY26E figures are author estimates anchored on company guidance (single-digit revenue growth; segment margin targets).

Quarterly dynamics — last 5 quarters
Metric	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue ($M)	153.2	156.4	175.0	146.7	156.3
Gross margin %	22%	23%	24%	21%	23%
Net income ($M)	−2.1	3.8	4.2	−2.9	8.3
End-of-period cash ($M)	41	38	36	32	35.5

Financial position and sustainability

Net leverage vs. covenant ceiling

1.5x / 3.5x

Evergreen capex funded (post-secondary)

$100M / $320M

FY26 guidance progress (Q1 actual vs. annual)

24% / 100%

account_tree

Business model — multi-segment energy services + critical-minerals optionality

A profitable oilfield-services core funding a critical-minerals option

TTI runs two reporting segments — Completion Fluids & Products and Water & Flowback Services — that together produce $630M of revenue and stable EBITDA. Embedded within Completion Fluids is the bromine franchise (clear brine fluids, zinc bromide for energy storage), which provides both a current revenue stream and the upstream IP/supply position for the Arkansas Evergreen bromine plant. The investment thesis is binary: pay an oilfield-services premium today (~19.7x EV/EBITDA) for the right to own a domestic vertically-integrated bromine producer in 2028. The May-26 FID approval and June-26 $100M raise materially de-risked the path; remaining risk is execution and incremental funding for 2027-28 capex peak.

Completion Fluids & Products ~$300-320M FY26E (~45% rev) 🟢 ramping Clear brine fluids, additives, calcium chloride, PureFlow zinc bromide for batteries. Q1-26 record EBITDA contribution. Argentina EPF contracts ramping in H2-26. Target margin 25-30%. Water & Flowback Services ~$320-340M FY26E (~50% rev) 🟡 cyclical Water management, frac flowback, production testing for US/intl onshore upstream. Cyclical with rig count. Target margin mid-teens. Sandstorm Middle East awards adding diversification. Evergreen Bromine (pre-revenue) ~$0 today → $150-200M by 2030 🟢 FID approved Southwest Arkansas plant, 75M lbs/yr capacity, first production targeted Q1-28. Project NPV $607M per company. Magrathea Metals JV (Dec 2025) adds magnesium co-product. Lithium evaluation ongoing.

gavel

Legal, regulatory and risk analysis

Execution risk on Evergreen capex

High

$220M+ remaining capex through 2028 startup. Construction slip, cost overrun or commodity-driven NPV erosion would compress the $2.91/sh probability-weighted contribution materially. Phase-2-to-3 transition milestone in H2-26.

Further equity dilution 2027-28

Moderate

Management acknowledged additional capital sources may be required as build-out accelerates. Modeled $150M further secondary in base case ($0.58/sh haircut); bear case could see $300M+ at depressed price.

Oilfield services cyclicality

Moderate

~50% of revenue from Water & Flowback Services, levered to US/international rig count and frac activity. Sustained oil price drop below $60 WTI would cut Q-on-Q EBITDA 20-30%.

Bromine price assumption in NPV

Moderate

$607M NPV assumes mid-cycle bromine pricing. Chinese supply discipline + energy-storage demand currently supportive; but ALB & ICL adjusting capacity could move prices ±20%.

Insider buying signal

Positive

VP-Treasurer & IR Hallead — third open-market purchase since May 2025, 22,000 shares ($217K). Holdings 0 → 170,764. No insider selling. Credible alignment with public thesis.

FID approval + secondary completed

Positive

May 28 final investment decision and June 2 $100M raise remove the two biggest overhangs going into FID approval. Path to production now sequence-of-construction risk, not a sequence-of-funding risk.

No class action, no governance flags

Low

No active securities class action; no short-seller report in last 12 months; no SEC investigation. CFO retirement orderly (Serrano → Sanderson, announced Oct 2025). NYSE compliance full.

Lithium optionality fading

Moderate

Lithium prices off cycle highs; management timing of large-scale plant pushed to mid-2027 earliest. Lithium contribution to FV ($0.43/sh) at risk of going to zero in bear case.

article

SWOT analysis

Strengths

+Profitable multi-segment platform: $631M revenue, $118M EBITDA, 1.5x leverage
+Vertically integrated bromine upstream position with FID-approved expansion
+Argentina EPF contracts doubling local revenue in 2026
+Credible insider buying (treasurer/IR) and orderly CFO transition
+No class action, no governance red flags, NYSE compliance full

Weaknesses

−EV/EBITDA TTM 19.7x — 4-5x premium to oilfield-services peers, prices in most optionality
−Free cash flow tiny ($224k levered TTM); capex-heavy years ahead
−Net income $3M FY25 distorted by one-off items; underlying earnings power modest
−10.8% dilution YoY from June secondary; more raises likely 2027-28
−No buyback, no dividend — capital fully consumed by growth program

Opportunities

→2028 first bromine production — re-rating to specialty-chemicals multiple (8-10x)
→Magrathea JV converting magnesium to commercial production
→US tariffs on Chinese bromine create domestic-supply pricing tailwind
→PureFlow zinc bromide demand from grid-scale energy storage
→Long-term revenue target $1.2-1.3B by 2030 — ~80% upside from 2026 base

Threats

!Construction slip on Evergreen pushes first revenue from 2028 to 2029+
!Bromine pricing pressure from ALB/ICL capacity decisions
!US recession compressing upstream activity and oilfield services revenue
!Equity raise at depressed price if 2027 capex outpaces FCF + balance sheet
!Multiple compression if market sentiment on critical-minerals story cools

article

Summary by assessment area

🟡 Financial risk — Moderate

Leverage 1.5x → 0.4x post-secondary, comfortable
FCF tiny pre-Evergreen monetization
2027-28 capex peak requires further capital

🟢 Execution risk — Reduced after FID

FID approved May 2026, $100M raise priced June 2
Phase 2 of Arkansas construction on track
First production targeted Q1 2028

🟡 Valuation risk — Elevated

EV/EBITDA 19.7x vs peer median ~5x
FV $10.40 ≈ market price → minimal margin of safety
Asymmetry hypothesis weakened; ratio ~0.9x not ≥2.5x

2026-07-28 earnings

Q2 2026 Earnings Release

short-term Impact: High Direction: Binary

First quarterly update post-FID and post-secondary. Will confirm whether Q1 EBITDA strength persists and whether Argentina EPF contracts are contributing as guided. Margin expansion in Completion Fluids the key tell.

2026-09-30 operational

Argentina EPF revenue ramp confirmation (Q3-26)

medium-term Impact: Medium Direction: Bullish

Management has guided Argentina revenue doubling in 2026 via new early production facility contracts. Q3 update will reveal whether the ramp is on schedule and contributing to international segment growth.

2026-12-31 operational

Evergreen Arkansas — Phase 2 to Phase 3 construction transition

medium-term Impact: High Direction: Bullish

Final construction phase targeted for 2027 per company timeline. On-time transition is the single biggest signal that 2028 first-production target is intact. Slip would compress NPV and trigger multiple compression.

2026-10-28 earnings

Q3 2026 Earnings Release

medium-term Impact: High Direction: Binary

Should include first hard data on Sandstorm Middle East awards contribution and full-year FY26 guidance refresh. Capital plan for 2027 will be a focus given upcoming capex peak.

2027-02-28 capital_markets

FY2027 capital plan + funding strategy (FY26 results call)

long-term Impact: High Direction: Binary

FY26 full-year call will reveal 2027 capex magnitude and funding mix (FCF vs. debt vs. equity). Further dilution at $10+ acceptable; raise at $7-8 would damage FV materially.

2026-12-31 partnership

Magrathea Metals JV — magnesium milestone update

medium-term Impact: Medium Direction: Bullish

JV announced Dec 2025 to produce magnesium in Arkansas. Pilot-scale validation and commercial off-take by year-end would add a third critical-minerals leg and support specialty-chemicals multiple.

2028-03-31 product

Arkansas bromine plant — first production

long-term Impact: High Direction: Bullish

First production targeted Q1 2028; ramp to full 75M lbs/yr capacity through 2030. Triggers re-rating to specialty-chemicals multiple and crystallizes Evergreen NPV in earnings.

{ "verdict_label": {"it": "Giudizio: Moderatamente Attraente", "en": "Verdict: Moderately Attractive"}, "verdict_text": {"it": "TETRA Technologies (TTI): going concern profittevole con opzionalita' bromo/litio. FID Arkansas approvato e secondary $100M assorbito, ma EV/EBITDA 19.7x prezza gia' il 70% della tesi. Fair value $10.40 vicino al prezzo. Asimmetria attesa nello screening non si materializza pienamente: ratio circa 0.9x.", "en": "TETRA Technologies (TTI): profitable going concern with bromine/lithium optionality. Arkansas FID approved and $100M secondary absorbed, but EV/EBITDA 19.7x already prices in ~70% of the thesis. Fair value $10.40 close to market price. Screening-hypothesized asymmetry only partially holds: ratio ~0.9x."}, "bull_points": [ {"it": "FID Arkansas bromine approvato maggio 2026, NPV progetto $607M", "en": "Arkansas bromine FID approved May 2026, $607M project NPV"}, {"it": "Argentina EPF contracts raddoppiano ricavi locali nel 2026", "en": "Argentina EPF contracts doubling local revenue in 2026"}, {"it": "Insider buying credibile (treasurer/IR 3 acquisti dal mag 2025)", "en": "Credible insider buying (treasurer/IR 3 purchases since May 2025)"} ], "bear_points": [ {"it": "EV/EBITDA TTM 19.7x vs mediana oilfield services circa 5x", "en": "EV/EBITDA TTM 19.7x vs oilfield-services peer median ~5x"}, {"it": "Diluzione +10.8% YoY; altre raccolte probabili 2027-28", "en": "10.8% YoY dilution; further raises likely 2027-28"}, {"it": "FCF residuale ($224k TTM); execution risk Evergreen elevato", "en": "Residual FCF ($224k TTM); high Evergreen execution risk"} ], "risks": [ {"it": "Slip costruzione bromo oltre 2028 erode NPV $2.91/az", "en": "Bromine construction slip past 2028 erodes $2.91/sh NPV"}, {"it": "Ulteriore equity raise a prezzo depresso ($7-8) danneggia FV", "en": "Further equity raise at depressed price ($7-8) damages FV"}, {"it": "Compressione multiplo se sentiment su critical minerals si raffredda", "en": "Multiple compression if critical-minerals sentiment cools"} ] }

Sources & Disclaimer

Sources: Stockanalysis.com (price history via S&P Global Market Intelligence), Yahoo Finance, CNN Markets, TETRA Technologies Q1-26 earnings release (Apr 29, 2026), TETRA FY25 10-K, June 2 2026 secondary prospectus (424B5), May 28 2026 FID press release, StockTitan, Tipranks, Insider Form 4 (Hallead). Market data — last verified close 2026-06-18 (Juneteenth Jun 19 = NYSE closed): TTI $10.24, market cap ~$1.50B, 52W: $3.06–$12.54, ~146M shares post-secondary. Short interest: ~6.5%. Insider buying credible (Treasurer/IR Hallead, 3 purchases since May 2025, $217K most recent). No class action, no short-seller report, no SEC investigation in last 12 months. ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.